glp 1 risks and benefits GLP-1 receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Alastin Program:12 Week Program Some patients have reported

glp 1 risks and benefits GLP-1 receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Alastin Program:12 Week Program Some patients have reported

Some patients have reported a kind of emotional flattening while on GLP-1 drugs. Online, the phenomenon has taken on a name — anhedonia — and, more colloquially, “Ozempic personality.”

GLP-1 Receptor Agonist Discontinuation Among Patients With Obesity and/or Type 2 Diabetes

Alastin

Program:12 Week Program

The medication is compounded by licensed 503A pharmacies and available in all 50 states without insurance